FR2413912A1 - Frozen biogenic foetal material in normal saline - for regeneration and re-organisation of cells - Google Patents

Frozen biogenic foetal material in normal saline - for regeneration and re-organisation of cells

Info

Publication number
FR2413912A1
FR2413912A1 FR7800541A FR7800541A FR2413912A1 FR 2413912 A1 FR2413912 A1 FR 2413912A1 FR 7800541 A FR7800541 A FR 7800541A FR 7800541 A FR7800541 A FR 7800541A FR 2413912 A1 FR2413912 A1 FR 2413912A1
Authority
FR
France
Prior art keywords
regeneration
cells
frozen
biogenic
organisation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7800541A
Other languages
French (fr)
Other versions
FR2413912B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7800541A priority Critical patent/FR2413912A1/en
Publication of FR2413912A1 publication Critical patent/FR2413912A1/en
Application granted granted Critical
Publication of FR2413912B1 publication Critical patent/FR2413912B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmaceutical compsns. comprise >=1 cpds. of foetal origin and physiological saline soln. the compsn. then being rapidly frozen to avoid degradation. Starting materials include umbilical cord, allantoic fluid, Meckel's cartridge, placenta etc. The compsns. are useful for the regeneration and reorganisation of cells, e.g. for treatment of elderly patients, burns, varicose ulcers and nervous depression.
FR7800541A 1978-01-10 1978-01-10 Frozen biogenic foetal material in normal saline - for regeneration and re-organisation of cells Granted FR2413912A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7800541A FR2413912A1 (en) 1978-01-10 1978-01-10 Frozen biogenic foetal material in normal saline - for regeneration and re-organisation of cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7800541A FR2413912A1 (en) 1978-01-10 1978-01-10 Frozen biogenic foetal material in normal saline - for regeneration and re-organisation of cells

Publications (2)

Publication Number Publication Date
FR2413912A1 true FR2413912A1 (en) 1979-08-03
FR2413912B1 FR2413912B1 (en) 1981-05-29

Family

ID=9203253

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7800541A Granted FR2413912A1 (en) 1978-01-10 1978-01-10 Frozen biogenic foetal material in normal saline - for regeneration and re-organisation of cells

Country Status (1)

Country Link
FR (1) FR2413912A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530955A1 (en) * 1982-07-30 1984-02-03 Hecmati Michel ANTI-WRINKLE IMPLANT AND ITS MANUFACTURING METHOD
EP0249563A1 (en) * 1986-06-12 1987-12-16 Gérard Laumond Embryonic animal organ tissue extracts useful as stimulating agents for human organic metabolic functions
FR2613620A1 (en) * 1987-04-13 1988-10-14 Krom Robert Implant intended for human medicine
EP0299429A2 (en) * 1987-07-13 1989-01-18 Ludwig Dr. Schusteritz Preparation of a composition comprising immune cells from Wharton's jelly
EP0557148A1 (en) * 1992-02-18 1993-08-25 Raymond Bontemps Process for the preparation of a dietary supplement from embryonic tissues
MD839G2 (en) * 1992-07-21 1998-05-31 Alexandr Nicolaenco Biologically active agent having immunomodulating properties, method for its obtaining, preparation based on it and method for normalization of human and animal organism physiological state
MD838G2 (en) * 1992-07-21 1998-09-30 Alexandr Nicolaenco Biologically active agent having immunomodulating properties, method for its obtainig, pharmaceutical preparation based on it and method for normalization of human and animal organism physiological state
WO2001076611A1 (en) * 2000-04-10 2001-10-18 Genady Tikhonovich Sukhikh Method for preparing a cellular graft from fetal tissues
EA003301B1 (en) * 2000-04-28 2003-04-24 Научно-Производственное Республиканское Унитарное Предприятие "Диалек" Method for preparing a medicament from brain tissue of animal embryo and pharmaceutical composition based thereon
WO2012166004A1 (en) 2011-05-30 2012-12-06 Закрытое Акционерное Общество "Фарм-Синтез" Protein-polypeptide complex with a specific activity on the nervous system, process for preparing same and pharmaceutical composition on the basis thereof
WO2012166005A1 (en) 2011-05-30 2012-12-06 Закрытое Акционерное Общество "Фарм-Синтез" Protein-polypeptide complex with a specific activity on skin tissue, process for preparing same and pharmaceutical composition on the basis thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3186M (en) * 1962-02-28 1965-03-15 Balassa Leslie L Powders and cartilage extracts useful for wound healing.
FR4638M (en) * 1964-03-11 1966-12-05
FR7347M (en) * 1968-02-22 1969-10-13

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3186M (en) * 1962-02-28 1965-03-15 Balassa Leslie L Powders and cartilage extracts useful for wound healing.
FR4638M (en) * 1964-03-11 1966-12-05
FR7347M (en) * 1968-02-22 1969-10-13

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530955A1 (en) * 1982-07-30 1984-02-03 Hecmati Michel ANTI-WRINKLE IMPLANT AND ITS MANUFACTURING METHOD
WO1984000491A1 (en) * 1982-07-30 1984-02-16 Michel Hecmati Anti wrinkle implant
EP0249563A1 (en) * 1986-06-12 1987-12-16 Gérard Laumond Embryonic animal organ tissue extracts useful as stimulating agents for human organic metabolic functions
FR2599972A1 (en) * 1986-06-12 1987-12-18 Laumond Gerard EMBRYONIC TISSUE EXTRACTS OF ANIMAL ORGANS, INJECTABLE TO MAN
FR2613620A1 (en) * 1987-04-13 1988-10-14 Krom Robert Implant intended for human medicine
EP0299429A2 (en) * 1987-07-13 1989-01-18 Ludwig Dr. Schusteritz Preparation of a composition comprising immune cells from Wharton's jelly
EP0299429A3 (en) * 1987-07-13 1990-04-18 Ludwig Dr. Schusteritz Preparation of a composition comprising immune cells from wharton's jelly
EP0557148A1 (en) * 1992-02-18 1993-08-25 Raymond Bontemps Process for the preparation of a dietary supplement from embryonic tissues
MD839G2 (en) * 1992-07-21 1998-05-31 Alexandr Nicolaenco Biologically active agent having immunomodulating properties, method for its obtaining, preparation based on it and method for normalization of human and animal organism physiological state
MD838G2 (en) * 1992-07-21 1998-09-30 Alexandr Nicolaenco Biologically active agent having immunomodulating properties, method for its obtainig, pharmaceutical preparation based on it and method for normalization of human and animal organism physiological state
WO2001076611A1 (en) * 2000-04-10 2001-10-18 Genady Tikhonovich Sukhikh Method for preparing a cellular graft from fetal tissues
EA003301B1 (en) * 2000-04-28 2003-04-24 Научно-Производственное Республиканское Унитарное Предприятие "Диалек" Method for preparing a medicament from brain tissue of animal embryo and pharmaceutical composition based thereon
WO2012166004A1 (en) 2011-05-30 2012-12-06 Закрытое Акционерное Общество "Фарм-Синтез" Protein-polypeptide complex with a specific activity on the nervous system, process for preparing same and pharmaceutical composition on the basis thereof
WO2012166005A1 (en) 2011-05-30 2012-12-06 Закрытое Акционерное Общество "Фарм-Синтез" Protein-polypeptide complex with a specific activity on skin tissue, process for preparing same and pharmaceutical composition on the basis thereof

Also Published As

Publication number Publication date
FR2413912B1 (en) 1981-05-29

Similar Documents

Publication Publication Date Title
ES2035259T5 (en) PROCEDURE FOR THE MANUFACTURE OF AN ABSORBENT ARTICLE.
ES290656Y (en) DEVICE TO COLLECT AND KEEP CULTURES OF THE PATIENT'S BODY ALIVE.
DE59209658D1 (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF Wounds, SCARS AND KELOIDS
AR016798A1 (en) USE OF A LACTOBACILLUS CEPA FOR THE PREPARATION OF A MEDICINAL PRODUCT
DK0699103T3 (en) Surface-modified, biocompatible membranes
FR2413912A1 (en) Frozen biogenic foetal material in normal saline - for regeneration and re-organisation of cells
BR9910251A (en) Hematopoietic stimulation
PL372774A1 (en) Cotton swab used for cosmetic or medical purposes or for body care
ATA260087A (en) COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH CALCIUM ANTAGONISTS AND AN PRODUCT CONTAINING THEM FOR USE IN THE TREATMENT OF HIGH BLOOD PRESSURE
NL177501C (en) APPARATUS FOR GROWING ANIMAL AND HUMAN TISSUES IN THE FORM OF SINGLE-CELL LAYERS AND OF VIRUSES ON THESE TISSUE CULTURES.
DE60115432D1 (en) APOPTOTIC BODIES FOR USE IN THE TREATMENT OF T-CELL MEDICAMENT AND INFLAMMATORY DISEASES
NO913129D0 (en) NEW TROMBOLYTIC AGENT.
DE3582594D1 (en) PROGLUMID AND ITS PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF NEOPLASTIC AFFECTIONS.
ES2032922T3 (en) USE OF THE ANTAGONIC PAF-ACETER FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCEDURE TO DETERMINE THE EFFECTIVENESS OF THE SAME.
CO5280202A1 (en) TREATMENT METHODS AND TRAFFIC METHODS OF PHARMACOS
FI973185A0 (en) Use of melatonin in the treatment of patients with drug dependence
SU628904A1 (en) Anesthesia method
SE9101341D0 (en) NEW MEDICINAL USE
ATE181669T1 (en) USE OF REMACEMID TO TREAT PARKINSON'S DISEASE
ATE36333T1 (en) HYDANTOIN CONTAINING THERAPEUTIC AGENT.
DE3174977D1 (en) Bioactive composition containing vegetable agents
FI961029A (en) Procedure for the management of liver disease and corresponding indicators with vasodilating substances
RU95108976A (en) Warming-up medicinal agent
Johnson Refrigeration anesthesia
Maxwell Burns-the challenge of 1975

Legal Events

Date Code Title Description
CL Concession to grant licences
ST Notification of lapse
RN Application for restoration
IC Decision of the director general to declare irreceivable or to reject an appeal